Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study
The use of immunomodulators, immunosuppressants, and biologics has increased over time. However, exposure during pregnancy decreased, with recent years showing a lower rate of discontinuation. Understanding the factors influencing medication discontinuation during pregnancy can improve management strategies for women with autoimmune diseases.
Authors
- Sabine Mainbourg (ORCID: https://orcid.org/0000-0003-4564-2931)
- Jessica Gorgui
- Évelyne Vinet (ORCID: https://orcid.org/0000-0001-7727-5879)
- Anick Bérard
- Odile Sheehy (ORCID: https://orcid.org/0000-0002-6784-2080)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- HTC (Taiwan) (TW)
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Laboratoire de Biométrie et Biologie Evolutive (FR)
- Université de Montréal (CA)
Publication Details
- Journal
- BMC Pregnancy and Childbirth
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1186/s12884-024-06932-y
- Citations
- 1
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.54